Vaccine makers slash jobs, research as Kennedy tackles big pharma

New York Times: The Trump administration said it was not discouraging innovation.

But investors have grown hesitant to bet on a field that has fallen out of favor in Washington. Major manufacturers are reporting declining sales of their shots. Smaller companies are taking the brunt of the impact, with some stocks whipsawing in response to the changes.

Perhaps no vaccine maker has been hit harder by the federal policy changes than Moderna…